Tools · Private company
HALO Diagnostics
Track this companyFree. Adds HALO Diagnostics to your Dealase workspace and tells you when its record changes.
Clinical trials32 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- Axumin PET/CTPhase 2 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- MR-guided laser focal therapyProstate CancerClinicalTrials.gov · fetched Nov 12, 2026
- no interventions will be performed (observational)Cardiovascular DiseasesClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Phase I Human Analytics (HALO) StudyRECRUITING · started Mar 16, 2022ClinicalTrials.gov NCT05423860 · fetched Nov 12, 2026
- A Phase II Study to Evaluate Axumin PET/CT for Risk Stratification for Prostate CancerPHASE2 · COMPLETED · started Feb 27, 2018ClinicalTrials.gov NCT03373006 · fetched Nov 12, 2026
- Phase II Laser Focal Therapy of Prostate CancerACTIVE_NOT_RECRUITING · started May 1, 2016ClinicalTrials.gov NCT02243033 · fetched Nov 12, 2026